We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Frovatriptan as a Transitional Therapy in Medication Overuse Headache

This study is currently recruiting participants.
Verified August 2016 by Farnaz Amoozegar, University of Calgary
Sponsor:
ClinicalTrials.gov Identifier:
NCT01044251
First Posted: January 7, 2010
Last Update Posted: August 18, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Alberta Health Services
Information provided by (Responsible Party):
Farnaz Amoozegar, University of Calgary
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)